Irelli A - Search Results

1

Denosumab in breast cancer patients receiving aromatase inhibitors: A single-center observational study of effectiveness in adjuvant setting.

Irelli A, Sirufo MM, Scipioni T, Pietro F, Pancotti A, Ginaldi L, De Martinis M. Irelli A, et al. Indian J Cancer. 2021 Jan-Mar;58(1):136-139. doi: 10.4103/ijc.IJC_16_20. Indian J Cancer. 2021. PMID: 33402577 Free article. No abstract available.

2

New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting.

Cannita K, Paradisi S, Cocciolone V, Bafile A, Rinaldi L, Irelli A, Lanfiuti Baldi P, Zugaro L, Manetta R, Alesse E, Ricevuto E, Ficorella C. Cannita K, et al. Among authors: irelli a. Cancer Med. 2016 Sep;5(9):2232-9. doi: 10.1002/cam4.803. Epub 2016 Jul 15. Cancer Med. 2016. PMID: 27416882 Free PMC article.

3

mTOR Links Tumor Immunity and Bone Metabolism: What are the Clinical Implications?

Irelli A, Sirufo MM, Scipioni T, De Pietro F, Pancotti A, Ginaldi L, De Martinis M. Irelli A, et al. Int J Mol Sci. 2019 Nov 21;20(23):5841. doi: 10.3390/ijms20235841. Int J Mol Sci. 2019. PMID: 31766386 Free PMC article. Review.

4

Neuroendocrine Cancer of the Breast: A Rare Entity.

Irelli A, Sirufo MM, Morelli L, D'Ugo C, Ginaldi L, De Martinis M. Irelli A, et al. J Clin Med. 2020 May 13;9(5):1452. doi: 10.3390/jcm9051452. J Clin Med. 2020. PMID: 32414120 Free PMC article. Review.

5

Breast cancer patients receiving denosumab during adjuvant aromatase inhibitors treatment: who are the "inadequate responders" patients to denosumab?

Irelli A, Sirufo MM, Scipioni T, De Pietro F, Pancotti A, Ginaldi L, De Martinis M. Irelli A, et al. J BUON. 2020 Mar-Apr;25(2):648-654. J BUON. 2020. PMID: 32521848 Free article.

6

Sex and Gender Influences on Cancer Immunotherapy Response.

Irelli A, Sirufo MM, D'Ugo C, Ginaldi L, De Martinis M. Irelli A, et al. Biomedicines. 2020 Jul 21;8(7):232. doi: 10.3390/biomedicines8070232. Biomedicines. 2020. PMID: 32708265 Free PMC article. Review.

7

Real-life use of denosumab 120 mg every 12 weeks in prolonged treatment over 2 years of patients with breast cancer bone metastases.

Irelli A, Sirufo MM, D'Ugo C, Ginaldi L, De Martinis M. Irelli A, et al. J BUON. 2020 Jul-Aug;25(4):1799-1804. J BUON. 2020. PMID: 33099916 Free article.

8

Invasive Ductal Breast Cancer with Osteoclast-Like Giant Cells: A Case Report Based on the Gene Expression Profile for Changes in Management.

Irelli A, Sirufo MM, Quaglione GR, De Pietro F, Bassino EM, D'Ugo C, Ginaldi L, De Martinis M. Irelli A, et al. J Pers Med. 2021 Feb 23;11(2):156. doi: 10.3390/jpm11020156. J Pers Med. 2021. PMID: 33672165 Free PMC article.

9

The VES-13 and G-8 tools as predictors of toxicity associated with aromatase inhibitors in the adjuvant treatment of breast cancer in elderly patients: A single-center study.

Irelli A, Sirufo MM, Scipioni T, Aielli F, Martella F, Ginaldi L, Pancotti A, De Martinis M. Irelli A, et al. Indian J Cancer. 2021 Jun 25. doi: 10.4103/0019-509X.319470. Online ahead of print. Indian J Cancer. 2021. PMID: 34380841 Free article.

10

Allostatic Load as an Insight into the Psychological Burden after Primary Treatment in Women with Breast Cancer: Influence of Physical Side Effects and Pain Perception.

Irelli A, Ranieri J, Sirufo MM, De Pietro F, Casalena P, Ginaldi L, Cannita K, Di Giacomo D. Irelli A, et al. J Clin Med. 2022 Apr 12;11(8):2144. doi: 10.3390/jcm11082144. J Clin Med. 2022. PMID: 35456237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters